Case File №
#VI-2026-0854
Peptide Gurus
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
40 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Semaglutide | B Good | 6 | 6.5 | 5.9 | 7.3 | 16 Mar 2025 |
| BPC-157 | D Poor | 7 | 4.7 | 3.7 | 5.6 | 16 Mar 2025 |
| Ipamorelin | E Bad | 7 | 2.7 | 2.0 | 3.1 | 20 Mar 2025 |
| CJC-1295 | E Bad | 6 | 4.9 | 2.8 | 7.3 | 16 Mar 2025 |
| PT-141 | E Bad | 3 | 3.0 | 2.9 | 3.2 | 16 Mar 2025 |
| Retatrutide | E Bad | 7 | 0.8 | 0.0 | 5.4 | 16 Mar 2025 |
| Melanotan II | E Bad | 3 | 2.2 | 2.0 | 2.7 | 16 Mar 2025 |
| Tirzepatide | E Bad | 6 | 3.3 | 2.2 | 4.4 | 16 Mar 2025 |
| 4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 | X N/A | 3 | 4.0 | 1.9 | 7.2 | 23 May 2026 |
| 5-amino-1MQ | X N/A | 1 | 4.0 | 2.5 | 2.5 | 13 Jun 2025 |
| AA Water | X N/A | 2 | 4.0 | 3.5 | 3.8 | 23 May 2026 |
| ACE-031 | X N/A | 2 | 4.5 | 2.5 | 6.5 | 19 Jan 2026 |
| Adipotide | X N/A | 3 | 4.0 | 1.9 | 3.1 | 26 Jan 2026 |
| AICAR | X N/A | 4 | 4.0 | 2.5 | 7.4 | 24 May 2026 |
| BAC Water | X N/A | 3 | 4.7 | 1.6 | 8.2 | 19 Jan 2026 |
| BPC-157 Arg Oral | X N/A | 3 | 4.5 | 3.5 | 5.7 | 21 May 2026 |
| BPC157 10mg + TB500 10mg Blend | X N/A | 1 | 5.6 | 5.6 | 5.6 | 28 Mar 2025 |
| Bronchogen | X N/A | 4 | 4.0 | 2.0 | 3.4 | 21 May 2026 |
| Dianabol Raw | X N/A | 1 | 5.3 | 5.3 | 5.3 | 8 Jul 2025 |
| DSIP | X N/A | 3 | 4.0 | 2.1 | 5.0 | 20 May 2026 |
| Epithalon | X N/A | 3 | 4.0 | 2.9 | 4.0 | 24 May 2026 |
| Estradiol Cypionate | X N/A | 3 | 4.0 | 2.4 | 2.8 | 24 May 2026 |
| Finasteride | X N/A | 3 | 4.0 | 2.2 | 4.1 | 19 Jan 2026 |
| Fluoxymesterone (Halotestin) Raw | X N/A | 2 | 4.0 | 1.0 | 5.8 | 17 May 2026 |
| GHK-CU 2000mcg+Glutathione 200mg+Histidine 100mg+Glycine 50mg+NADH 50mg | X N/A | 4 | 4.0 | 2.9 | 6.0 | 19 Jan 2026 |
| GHRP-2 Acetate | X N/A | 3 | 4.0 | 2.8 | 4.8 | 24 May 2026 |
| IGF-1 LR3 | X N/A | 4 | 4.0 | 2.5 | 4.8 | 26 Jan 2026 |
| MGF | X N/A | 2 | 4.0 | 3.3 | 3.7 | 17 May 2026 |
| MOTS-C | X N/A | 2 | 4.0 | 2.1 | 3.9 | 20 May 2026 |
| MT-1 | X N/A | 2 | 4.2 | 3.2 | 5.2 | 20 May 2026 |
| N-Acetyl Epitalon Amidate | X N/A | 3 | 4.0 | 2.0 | 5.9 | 23 May 2026 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 3 | 4.0 | 0.9 | 7.0 | 20 May 2026 |
| NAD+ Injectable | X N/A | 1 | 4.0 | 2.5 | 2.5 | 8 Jul 2025 |
| PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | X N/A | 2 | 4.0 | 3.2 | 4.0 | 21 May 2026 |
| Retatrutide 30mg Pen Kit | X N/A | 1 | 5.6 | 5.6 | 5.6 | 8 Jul 2025 |
| SR9009 | X N/A | 2 | 4.0 | 2.1 | 2.9 | 17 May 2026 |
| Sustanon 250 | X N/A | 2 | 4.0 | 2.1 | 3.0 | 23 May 2026 |
| T3 (Liothyronine) | X N/A | 4 | 4.0 | 0.8 | 3.3 | 21 May 2026 |
| Vesugen | X N/A | 2 | 4.0 | 1.1 | 1.6 | 26 Jan 2026 |
| YK11 | X N/A | 2 | 4.0 | 4.0 | 4.0 | 25 May 2026 |
Exhibit II
Evidence Log
87 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | 4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 | 5.1 B | 500g | 468.5g | -6.3% | 97.18% | eyep8j | Lab G | Public |
| 25 May 2026 | N-Acetyl Epitalon Amidate | 4.0 C | 30mg | 37.1mg | +23.7% | 95.80% | 77q393 | Lab A | Public |
| 24 May 2026 | BAC Water | 4.0 C | 30mg | 32.6mg | +8.5% | 98.26% | 4cmlvs | Lab B | Public |
| 24 May 2026 | Bronchogen | 5.0 B | 20mg | 21.7mg | +8.5% | 97.34% | dkys43 | Lab D | Public |
| 24 May 2026 | MGF | 4.0 C | 10mg | 8.8mg | -12.5% | 98.36% | c5lwpr | Lab C | Public |
| 24 May 2026 | MT-1 | 4.0 C | 50mg | 48.8mg | -2.3% | 98.87% | 4lnam0 | Lab A | Public |
| 24 May 2026 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 7.9 A | 1g | 1.1g | +7.4% | 99.59% | evckhg | Lab F | Community |
| 24 May 2026 | Vesugen | 4.4 C | 10mg | 11.8mg | +18.2% | 95.49% | 4ztmck | Lab D | Community |
| 24 May 2026 | Fluoxymesterone (Halotestin) Raw | 4.6 C | 500g | 451.0g | -9.8% | 97.18% | q1d54y | Lab A | Community |
| 24 May 2026 | GHK-CU 2000mcg+Glutathione 200mg+Histidine 100mg+Glycine 50mg+NADH 50mg | 5.8 B | 200mg/ml | 173.1mg/ml | -13.4% | 99.53% | yj2ydp | Lab E | Community |
| 24 May 2026 | Bronchogen | 4.0 C | 20mg | 19.1mg | -4.7% | 98.20% | tlqrob | Lab C | Public |
| 24 May 2026 | N-Acetyl Epitalon Amidate | 4.4 C | 50mg | 52.6mg | +5.3% | 96.31% | flkloe | Lab D | Community |
| 24 May 2026 | 4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 | 4.0 C | 1g | 1.1g | +13.6% | 96.52% | 3zvlsd | Lab B | Public |
| 24 May 2026 | MGF | 4.5 C | 2mg | 2.0mg | -1.9% | 96.38% | e6qvag | Lab E | Public |
| 24 May 2026 | SR9009 | 5.3 B | 20mg | 21.6mg | +8.1% | 98.60% | iludoy | Lab G | Public |
| 24 May 2026 | Sustanon 250 | 4.0 C | 300mg/ml | 274.7mg/ml | -8.4% | 97.81% | tivmnf | Lab B | Community |
| 24 May 2026 | Estradiol Cypionate | 4.0 C | 300mg/ml | 318.7mg/ml | +6.2% | 95.54% | ksn6su | Lab B | Public |
| 23 May 2026 | DSIP | 4.0 C | 2mg | 2.0mg | +0.9% | 98.68% | ipjfsf | Lab F | Community |
| 23 May 2026 | GHRP-2 Acetate | 4.0 C | 20mg | 20.7mg | +3.3% | 98.57% | ujinhv | Lab A | Community |
| 21 May 2026 | DSIP | 4.3 C | 10mg | 9.2mg | -7.8% | 98.13% | acye3c | Lab C | Community |
| 21 May 2026 | Finasteride | 4.0 C | 20mg | 23.4mg | +17.2% | 99.42% | 21qblj | Lab C | Public |
| 21 May 2026 | AA Water | 4.1 C | 10mg | 9.6mg | -4.3% | 99.35% | 405yn6 | Lab G | Community |
| 21 May 2026 | BPC-157 Arg Oral | 4.8 C | 100mg | 115.6mg | +15.6% | 99.54% | fs7j7b | Lab E | Community |
| 21 May 2026 | T3 (Liothyronine) | 4.0 C | 100mg | 93.9mg | -6.1% | 98.49% | db7gfo | Lab C | Public |
| 20 May 2026 | MOTS-C | 4.0 C | 50mg | 52.7mg | +5.5% | 96.17% | gv0gzz | Lab D | Community |
| 19 May 2026 | GHRP-2 Acetate | 4.8 C | 30mg | 25.6mg | -14.6% | 98.11% | mi2lq7 | Lab C | Public |
| 17 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 4.8 C | 2mg | 2.3mg | +15.4% | 99.17% | rb7zle | Lab D | Public |
| 17 May 2026 | T3 (Liothyronine) | 4.0 C | 20mg | 24.6mg | +23.1% | 98.68% | wu6prm | Lab E | Community |
| 29 Jan 2026 | AICAR | 4.9 C | 20mg | 18.5mg | -7.6% | 98.47% | gvlfns | Lab E | Public |
| 29 Jan 2026 | BPC157 10mg + TB500 10mg Blend | 5.0 B | 30mg | 27.4mg | -8.8% | 98.98% | etsim0 | Lab B | Community |
| 26 Jan 2026 | BPC-157 Arg Oral | 7.0 A | 25mg | 25.9mg | +3.6% | 99.69% | sbexe6 | Lab G | Community |
| 26 Jan 2026 | DSIP | 4.0 C | 10mg | 12.1mg | +20.7% | 96.33% | bybxzv | Lab C | Public |
| 26 Jan 2026 | Retatrutide 30mg Pen Kit | 7.1 A | 20mg | 23.3mg | +16.4% | 95.24% | uy9p6y | Lab G | Community |
| 26 Jan 2026 | YK11 | 4.8 C | 10mg | 9.5mg | -5.0% | 97.69% | y29qjk | Lab C | Community |
| 19 Jan 2026 | GHK-CU 2000mcg+Glutathione 200mg+Histidine 100mg+Glycine 50mg+NADH 50mg | 4.4 C | 200mg/ml | 173.9mg/ml | -13.0% | 99.72% | pkouii | Lab C | Public |
| 9 Jan 2026 | N-Acetyl Epitalon Amidate | 4.9 C | 2mg | 2.1mg | +7.3% | 97.86% | uckuep | Lab C | Community |
| 7 Jan 2026 | NAD+ Injectable | 4.0 C | 200mg/ml | 232.4mg/ml | +16.2% | 99.17% | p85ezb | Lab E | Public |
| 6 Jan 2026 | MOTS-C | 4.0 C | 20mg | 19.7mg | -1.7% | 98.76% | p0qxi1 | Lab A | Community |
| 29 Dec 2025 | 4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 | 4.5 C | 10g | 9.9g | -0.6% | 95.38% | petelh | Lab C | Community |
| 29 Dec 2025 | Dianabol Raw | 6.2 A | 100g | 97.3g | -2.7% | 97.02% | 9ocvlt | Lab F | Public |
| 29 Dec 2025 | Estradiol Cypionate | 4.0 C | 300mg/ml | 277.9mg/ml | -7.4% | 99.94% | y07l0x | Lab A | Public |
| 29 Dec 2025 | GHK-CU 2000mcg+Glutathione 200mg+Histidine 100mg+Glycine 50mg+NADH 50mg | 5.0 B | 250mg/ml | 265.3mg/ml | +6.1% | 96.26% | qccroq | Lab D | Community |
| 29 Dec 2025 | GHRP-2 Acetate | 4.5 C | 50mg | 46.4mg | -7.1% | 97.07% | cfwkua | Lab E | Public |
| 29 Dec 2025 | IGF-1 LR3 | 4.6 C | 5mg | 4.6mg | -7.1% | 97.78% | uiw3ui | Lab D | Public |
| 29 Dec 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 4.3 C | 10mg | 12.3mg | +23.4% | 99.74% | 3acfkd | Lab A | Community |
| 12 Dec 2025 | ACE-031 | 4.0 C | 10mg | 11.6mg | +16.4% | 97.00% | rdpwdf | Lab C | Public |
| 12 Dec 2025 | Adipotide | 4.9 C | 30mg | 26.1mg | -13.0% | 98.87% | qp3vj4 | Lab D | Community |
| 12 Dec 2025 | BAC Water | 5.8 B | 2mg | 2.3mg | +15.7% | 98.12% | clyvg5 | Lab A | Community |
| 12 Dec 2025 | Epithalon | 4.1 C | 10mg | 9.4mg | -5.5% | 97.03% | zl3wen | Lab G | Public |
| 5 Dec 2025 | 5-amino-1MQ | 4.0 C | 15mg | 14.7mg | -2.2% | 99.78% | 95559p | Lab B | Public |
| 5 Dec 2025 | Epithalon | 4.6 C | 5mg | 4.3mg | -13.2% | 98.05% | y9pztt | Lab B | Public |
| 5 Dec 2025 | Finasteride | 5.0 B | 50mg | 53.5mg | +7.1% | 98.89% | kk1tg5 | Lab F | Public |
| 5 Dec 2025 | IGF-1 LR3 | 4.0 C | 2mg | 2.0mg | -0.0% | 97.44% | imatvz | Lab D | Public |
| 5 Dec 2025 | Sustanon 250 | 4.5 C | 200mg/ml | 182.0mg/ml | -9.0% | 95.91% | pb46s3 | Lab C | Community |
| 23 Nov 2025 | AA Water | 6.1 A | 30mg | 32.0mg | +6.8% | 97.56% | ksxs96 | Lab F | Community |
| 23 Nov 2025 | BPC-157 Arg Oral | 4.2 C | 20mg | 24.4mg | +21.9% | 98.20% | 6vw6zk | Lab E | Community |
| 23 Nov 2025 | Estradiol Cypionate | 4.8 C | 200mg/ml | 228.9mg/ml | +14.5% | 99.73% | hjt9di | Lab C | Public |
| 23 Nov 2025 | Finasteride | 4.0 C | 25mg | 25.9mg | +3.6% | 95.41% | s2k6z9 | Lab E | Public |
| 23 Nov 2025 | Fluoxymesterone (Halotestin) Raw | 5.8 B | 1g | 1.0g | -4.0% | 96.80% | 8hhdk0 | Lab F | Community |
| 17 Nov 2025 | Adipotide | 4.0 C | 15mg | 17.6mg | +17.3% | 98.49% | z5op5g | Lab C | Public |
| 17 Nov 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 4.0 C | 50mg | 59.7mg | +19.5% | 97.90% | 9e971f | Lab G | Public |
| 17 Nov 2025 | YK11 | 5.2 B | 100mg | 99.6mg | -0.4% | 95.65% | 7lxpvi | Lab B | Public |
| 14 Nov 2025 | IGF-1 LR3 | 4.0 C | 2mg | 2.1mg | +7.0% | 97.69% | w9ge20 | Lab G | Public |
| 5 Nov 2025 | AICAR | 4.0 C | 10mg | 11.9mg | +18.6% | 98.44% | 1fgzzz | Lab A | Public |
| 5 Nov 2025 | BAC Water | 6.0 A | 10mg | 10.7mg | +7.3% | 99.12% | w3rc7x | Lab E | Community |
| 5 Nov 2025 | IGF-1 LR3 | 4.0 C | 2mg | 1.8mg | -12.0% | 96.09% | fzqzrv | Lab B | Community |
| 5 Nov 2025 | T3 (Liothyronine) | 4.9 C | 20mg | 18.2mg | -9.0% | 97.26% | xd6ijn | Lab A | Public |
| 4 Nov 2025 | Adipotide | 4.0 C | 50mg | 44.1mg | -11.8% | 95.03% | 935n2f | Lab C | Community |
| 4 Nov 2025 | AICAR | 4.0 C | 10mg | 12.2mg | +22.3% | 98.41% | gaa9tz | Lab F | Public |
| 4 Nov 2025 | Epithalon | 4.0 C | 20mg | 21.1mg | +5.7% | 95.83% | mbwer4 | Lab D | Public |
| 4 Nov 2025 | T3 (Liothyronine) | 4.0 C | 50mg | 51.5mg | +3.0% | 99.33% | 47njoz | Lab G | Public |
| 17 Oct 2025 | ACE-031 | 4.6 C | 30mg | 29.0mg | -3.4% | 96.63% | xw0t1b | Lab F | Community |
| 17 Oct 2025 | AICAR | 4.6 C | 15mg | 16.9mg | +12.6% | 95.21% | dqj181 | Lab G | Public |
| 17 Oct 2025 | Bronchogen | 6.2 A | 20mg | 18.2mg | -8.8% | 97.26% | pu9do6 | Lab C | Public |
| 17 Oct 2025 | Bronchogen | 4.0 C | 5mg | 5.8mg | +15.6% | 98.64% | gdlo5c | Lab F | Community |
| 17 Oct 2025 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 4.5 C | 500g | 523.8g | +4.8% | 98.30% | fpktk2 | Lab A | Community |
| 17 Oct 2025 | Vesugen | 4.0 C | 5mg | 5.9mg | +17.2% | 96.71% | pfy7wa | Lab A | Public |
| 9 Oct 2025 | MT-1 | 5.2 B | 2mg | 2.3mg | +17.5% | 97.17% | 5ba6vd | Lab C | Public |
| 9 Oct 2025 | SR9009 | 4.0 C | 100mg | 116.9mg | +16.9% | 99.18% | bmcqa8 | Lab E | Public |
| 3 Oct 2025 | GHK-CU 2000mcg+Glutathione 200mg+Histidine 100mg+Glycine 50mg+NADH 50mg | 4.0 C | 300mg/ml | 363.2mg/ml | +21.1% | 96.06% | wf95bm | Lab A | Community |
| 3 Jul 2025 | Retatrutide | 5.4 C | 5mg | 4.91mg | -1.8% | 98.39% | (no batch ID) | Lab E | Public |
| 15 May 2025 | BPC-157 | 5.0 C | 5mg | 4.86mg | -2.8% | 96.97% | (no batch ID) | Lab A | Public |
| 14 May 2025 | Ipamorelin | 2.0 E | 5mg | 3.4mg | -32.0% | 98.16% | (no batch ID) | Lab A | Public |
| 27 Mar 2025 | Retatrutide | 0.0 E | 10mg | ⚠️ Sample does not contain Retatrutide ? | (no batch ID) | No Label / Silver Crimp / White caps | Lab C | — | — |
| 27 Mar 2025 | Retatrutide | 0.0 E | 10mg | ⚠️ Sample does not contain Retatrutide ? | (no batch ID) | No Label / Silver Crimp / White caps | Lab C | — | — |
| 27 Mar 2025 | Retatrutide | 0.0 E | 10mg | ⚠️ Sample does not contain Retatrutide ? | (no batch ID) | No Label / Silver Crimp / White caps | Lab C | — | — |
| 25 Mar 2025 | Semaglutide | 7.3 A | 5mg | 5.35mg | +7.0% | 99.91% | (no batch ID) | Lab C | VendorInvestigator |
— END OF EVIDENCE LOG —